NASDAQ: EMBCEmbecta Corp Stock Ownership - Who owns Embecta?
Insider buying vs selling
Have Embecta Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Devdatt Kurdikar | President and CEO | 2024-04-04 | 4,535 | $12.78 | $57.96kSell |
| David F. Melcher | Director | 2024-02-12 | 2,000 | $16.25 | $32.50kBuy |
| Devdatt Kurdikar | President and CEO | 2024-02-11 | 17,165 | $16.26 | $279.10kSell |
| Brian Capone | VP CAO Corp. Controller | 2023-11-26 | 892 | $17.49 | $15.60kSell |
| Devdatt Kurdikar | President and CEO | 2023-11-26 | 18,431 | $17.49 | $322.36kSell |
| Shaun Curtis | SVP Global Manuf.Sup. Chain | 2023-11-26 | 4,351 | $17.49 | $76.10kSell |
| Jacob Elguicze | SVP and CFO | 2023-11-26 | 5,486 | $17.49 | $95.95kSell |
| Jeffrey Z. Mann | SVP GC Head Corp. Dev. Secy | 2023-11-26 | 3,715 | $17.49 | $64.98kSell |
| David F. Melcher | Director | 2023-09-08 | 6,233 | $15.77 | $98.27kBuy |
| Jacob Elguicze | SVP and CFO | 2023-08-10 | 4,625 | $21.66 | $100.20kBuy |
EMBC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when EMBC insiders and whales buy or sell their stock.
EMBC Shareholders
What type of owners hold Embecta Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 16.37% | 9,427,335 | $102.57M | Institution |
| Vanguard Group Inc | 12.20% | 7,026,076 | $76.44M | Institution |
| Millennium Management LLC | 6.31% | 3,635,948 | $39.56M | Institution |
| River Road Asset Management LLC | 5.75% | 3,310,749 | $36.02M | Institution |
| Yacktman Asset Management LP | 4.64% | 2,671,237 | $29.06M | Institution |
| American Century Companies Inc | 4.53% | 2,610,526 | $28.40M | Institution |
| State Street Corp | 4.37% | 2,516,911 | $27.38M | Institution |
| Fmr LLC | 4.12% | 2,373,840 | $25.83M | Institution |
| Janus Henderson Group PLC | 3.03% | 1,746,137 | $19.00M | Institution |
| Deerfield Management Company LP Series C | 2.41% | 1,384,839 | $15.07M | Institution |
EMBC vs Medical Stocks
Embecta Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.